Abrdn Life Sciences Investors (HQL)
NYSE: HQL · Real-Time Price · USD
17.50
-0.03 (-0.17%)
Apr 29, 2026, 9:30 AM EDT - Market open
HQL Cash Flow Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
| FY 2025 | FY 2024 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 |
| Net Income | 85.59 | - | - | - | - | |
| Loss (Gain) From Sale of Investments | -88.97 | - | - | - | - | |
| Other Operating Activities | 35.29 | - | - | - | - | |
| Change in Accounts Receivable | 0.06 | - | - | - | - | |
| Change in Other Net Operating Assets | -0.26 | - | - | - | - | |
| Operating Cash Flow | 31.71 | - | - | - | - | |
| Common Dividends Paid | -31.63 | - | - | - | - | |
| Financing Cash Flow | -31.63 | - | - | - | - | |
| Net Cash Flow | 0.08 | - | - | - | - | |
| Levered Free Cash Flow | -2.18 | - | - | - | - | |
| Unlevered Free Cash Flow | -2.18 | - | - | - | - | |
| Change in Working Capital | -0.2 | - | - | - | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.